{
    "applicationNumber": "BR 11 2023 000810-7",
    "filingDate": "07/03/2022",
    "grantDate": null,
    "title": "ANTICORPO OU FRAGMENTO DE ANTICORPO, \u00c1CIDO NUCLEICO ISOL\u00c1VEL, VETOR DE EXPRESS\u00c3O, C\u00c9LULA HOSPEDEIRA, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, USO DO ANTICORPO OU FRAGMENTO DE ANTICORPO, COMBINA\u00c7\u00c3O FARMAC\u00caUTICA, E, M\u00c9TODOS PARA INIBIR A ATIVIDADE DE PROTE\u00cdNA DE PVRIG E PARA PREVENIR OU TRATAR C\u00c2NCER",
    "nationalPhaseDate": [
        "16/01/2023"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2022/079449",
        "pctDate": "07/03/2022",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "202110250342.9",
            "priorityDate": "08/03/2021"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2716"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2750"
        }
    ],
    "inventors": [
        "ZHIGANG TIAN",
        "YANGYANG LI",
        "WEIHUA XIAO",
        "RUI SUN",
        "HAOYU SUN"
    ],
    "holders": [
        335031
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 39/395",
        "G01N 33/574",
        "C07K 16/28",
        "C12N 15/13"
    ]
}